Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluvoxamine 100mg tablets
0403030L0AAABAB
|
Fluvoxamine maleate | Fluvoxamine maleate | Central Nervous System | 3,544 |
|
Fluvoxamine 50mg tablets
0403030L0AAAAAA
|
Fluvoxamine maleate | Fluvoxamine maleate | Central Nervous System | 3,035 |
|
Faverin 100mg tablets
0403030L0BBABAB
|
Faverin | Fluvoxamine maleate | Central Nervous System | 238 |
|
Faverin 50mg tablets
0403030L0BBAAAA
|
Faverin | Fluvoxamine maleate | Central Nervous System | 204 |
|
Fluvoxamine 50mg/5ml oral suspension
0403030L0AAAEAE
|
Fluvoxamine maleate | Fluvoxamine maleate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.